| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/19/2007 | US20070087057 Hydrogel-Driven Drug Dosage Form |
| 04/19/2007 | US20070087051 Pharmaceutical composition |
| 04/19/2007 | US20070087047 Enhanced circulation effector composition and method |
| 04/19/2007 | US20070087038 Gelling compositions and methods |
| 04/19/2007 | US20070087037 Stimulation of cpt-1 as a means to reduce weight |
| 04/19/2007 | US20070087036 Edible film for transmucosal delivery of nutritional supplements |
| 04/19/2007 | US20070087035 Nutritional composition for wound healing |
| 04/19/2007 | US20070087014 Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 04/19/2007 | US20070087006 Compositions and methods for the diagnosis and treatment of tumor |
| 04/19/2007 | US20070087004 Pro104 antibody compositions and methods of use |
| 04/19/2007 | US20070086995 Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations |
| 04/19/2007 | US20070086993 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 04/19/2007 | US20070086992 stimulating antitumor immune responses; tissue-targeted therapy; first tumour antigen is used to treat secondary tumor; biodrug for cancer immunotherapy with cyclophosphamide |
| 04/19/2007 | US20070086981 Delivery peptides, their constructs with active agents and use |
| 04/19/2007 | US20070086978 Colon cleansing compositions and methods |
| 04/19/2007 | US20070086975 Polymeric micellar complexes and drug delivery vehicles thereof |
| 04/19/2007 | US20070086956 Method for accelerating the rate of mucociliary clearance |
| 04/19/2007 | CA2625804A1 Pharmaceutical composition based on a morpholinic antimycotic agent and a water-soluble film-forming agent for ungual and periungual application |
| 04/19/2007 | CA2625532A1 Agent for applying to mucosa containing a hydrophobic group binding type glycosaminoglycan |
| 04/19/2007 | CA2625084A1 Pth formulations and methods of use |
| 04/19/2007 | CA2624910A1 Biocompatible block copolymer, use thereof, and production method thereof |
| 04/19/2007 | CA2624867A1 Antithrombotic compound |
| 04/19/2007 | CA2624841A1 Conjugates of photosensitisers and antibodies |
| 04/19/2007 | CA2624677A1 System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids |
| 04/19/2007 | CA2624588A1 Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| 04/19/2007 | CA2623749A1 Reduction of saltiness with sweeteners |
| 04/19/2007 | CA2623542A1 Methods of preparing polymers having terminal amine groups using protected amine salts |
| 04/19/2007 | CA2622342A1 Processing of chitosan and chitosan derivatives |
| 04/18/2007 | EP1775305A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 04/18/2007 | EP1774978A1 Application of hyaluronic acid to sentinel lymph node identification |
| 04/18/2007 | EP1774969A2 Controlled release oxycodone compositions |
| 04/18/2007 | EP1774967A1 Solid oral dosage forms comprising valsartan |
| 04/18/2007 | EP1774961A2 Methods for stabilizing ophthalmic compositions |
| 04/18/2007 | EP1773936A2 Unagglomerated core/shell nanocomposite particles |
| 04/18/2007 | EP1773914A1 Polyamino acids functionalised by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications |
| 04/18/2007 | EP1773400A2 Therapeutic peptides |
| 04/18/2007 | EP1773399A1 Hydrogels of hyaluronic acid and alpha, beta-polyaspartylhydrazide and their biomedical and pharmaceutical uses |
| 04/18/2007 | EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 04/18/2007 | EP1773353A2 Formulations for parenteral administration of (e)-2,6-dialkoxystryryl 4-substituted benzylsulfones |
| 04/18/2007 | EP1773350A2 Opthalmic compositions and methods for treating ophthalmic conditions |
| 04/18/2007 | EP1773336A1 Use of a steroid for enhancement of skin permeability |
| 04/18/2007 | EP1773312A1 Composition containing statins and omega-3 fatty acids |
| 04/18/2007 | EP1773307A1 Compound formulations of 2-amino-1,3-propanediol compounds |
| 04/18/2007 | EP1773297A1 Infusion and injection solution of levodopa |
| 04/18/2007 | EP1773240A2 Silk-based drug delivery system |
| 04/18/2007 | EP1677777B1 Pellets containing venlafaxine hydrochloride |
| 04/18/2007 | EP1556061B1 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 04/18/2007 | EP1480636B1 Self emulsifying drug delivery systems for taxoids |
| 04/18/2007 | EP1478350B1 Pharmaceutical dosage forms comprising tablet core having a tensile strength below 38 n/sqcm and a coating to protect the soft core |
| 04/18/2007 | EP1453545B1 Water-soluble polymer conjugates of retinoic acid |
| 04/18/2007 | EP1439859B1 An antineoplastic- dendritic polymer drug delivery system |
| 04/18/2007 | EP1432406B1 Pharmaceutical composition comprising a water/oil/water double microemulsion incorporated in a solid support |
| 04/18/2007 | EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 04/18/2007 | EP1379266B1 Modified annexin proteins and prevention and treatment of thrombosis |
| 04/18/2007 | EP1343525B1 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1201232B1 Patches for external use |
| 04/18/2007 | EP1180368B1 Freeze dried hgf preparations |
| 04/18/2007 | EP1144010B1 Prevention of chronic graft rejection by a combination of immunotoxins and costimulation blockers |
| 04/18/2007 | EP1135160B1 Boron neutron capture therapy using pre-targeting methods |
| 04/18/2007 | EP1090036B1 Site specific protein modification by mutagenesis |
| 04/18/2007 | EP1024835B1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/18/2007 | EP1007080B1 Formulation for the sustained release of peptide agonists and analogues of GnRH |
| 04/18/2007 | EP1005374B1 Microparticles for delivery of nucleic acid |
| 04/18/2007 | CN1950427A Perfluoropolyether containing acrylat groups |
| 04/18/2007 | CN1950110A Cyclodextrin inclusion complexes of pyrimidine-2,4,6-triones |
| 04/18/2007 | CN1950109A Compositions comprising cells and magnetic materials for targeted delivery |
| 04/18/2007 | CN1950100A Multi-component biological transport systems |
| 04/18/2007 | CN1950073A Nutritional composition for increasing creatine uptake in skeletal muscle |
| 04/18/2007 | CN1950070A Process for producing medicine |
| 04/18/2007 | CN1948362A Poly carbonate containing phenyl group and its synthesis method and use |
| 04/18/2007 | CN1947797A Traditional Chinese medicine mate |
| 04/18/2007 | CN1947796A Chemical modified adefovir and tynofovir |
| 04/18/2007 | CN1947795A Method for preparing composite nano-polymers to inhibit tumor multidrug resistance |
| 04/18/2007 | CN1947721A Method for preparing epirubicin slow-release prepn |
| 04/18/2007 | CN1947716A Clathrate compound of alpha-lipoic acid-cyclodextrin derivatives, and its prepn. method |
| 04/18/2007 | CN1947714A Oridonin clathrate compound, and medicinal prepn. thereof |
| 04/18/2007 | CN1947707A Floated in staomach type slow-release tablets contg. berberine hydrochloide and its prepn. method |
| 04/18/2007 | CN1947706A Slow-release, controlled-release prepn. contg. chlortenozicam |
| 04/18/2007 | CN1947704A Medicinal water-soluble compositions contg. 20(R)-ginsenoside (Rg3), and its prepn. method |
| 04/18/2007 | CN1947703A Stable elaioplast compositions |
| 04/18/2007 | CN1947702A Lipid carrier and method of preparing the same |
| 04/18/2007 | CN1947700A Sustained release Brufen having magnetic super-molecular inserting layer structure and its prpen. method |
| 04/18/2007 | CN1947699A Method for producing water soluble fluorophenylnico |
| 04/18/2007 | CN1310682C Antibiotic coating of porous body, its prepn. and application |
| 04/18/2007 | CN1310679C Method of achieving persistent transgene expression |
| 04/18/2007 | CN1310676C Method for improving immune response |
| 04/18/2007 | CN1310671C Sustained-release compositions for injection and process for producing the same |
| 04/18/2007 | CN1310648C A topical nanoparticulate spironolactone formulation |
| 04/18/2007 | CN1310643C Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent |
| 04/18/2007 | CN1310642C Methods and compositions to enhance white blood cell count |
| 04/18/2007 | CN1310628C Heat generating article |
| 04/17/2007 | USRE39573 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 04/17/2007 | US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor |
| 04/17/2007 | US7205380 drug and/or biological conjugates comprising water-soluble and non-peptidic polyethers, having hydrolytic stability, used for drug delivery; prodrugs |
| 04/17/2007 | US7205378 therapeutic agent is reversibly immobilized on polymer matrix using ionic complexation between latent carboxylic groups present on the lactone bearing polymer matrix and a cationic group on the therapeutic agent; drug delivery |
| 04/17/2007 | US7205343 Stabilized bioactive preparations and method of use |
| 04/17/2007 | US7205337 End-capped polymers and compositions containing such compounds |
| 04/17/2007 | US7205282 Remedies for hepatitis |
| 04/17/2007 | US7205277 Zinc-free and low-zinc insulin preparations having improved stability |